Journal
/
/
Drug Screening of Primary Patient Derived Tumor Xenografts in Zebrafish
JoVE Journal
Pesquisa do Câncer
É necessária uma assinatura da JoVE para visualizar este conteúdo.  Faça login ou comece sua avaliação gratuita.
JoVE Journal Pesquisa do Câncer
Drug Screening of Primary Patient Derived Tumor Xenografts in Zebrafish
DOI:

09:50 min

April 10, 2020

, ,

Capítulos

  • 00:04Introduction
  • 00:54Fluorescently Labeling Cells with DiI(1,1 -Dioctadecyl-3,3,3 ,3 -Tetramethylindocarbocyanine Perchlorate)
  • 02:10Microinjecting Zebrafish Larvae
  • 04:37Setting up Drug Screen with Xenografted Zebrafish
  • 06:22Imaging Xenografted Zebrafish and Quantifying Fluorescence
  • 08:36Results: Xenografted Tumor Area
  • 09:22Conclusion

Summary

Tadução automática

Zebrafish xenograft models allow for high-throughput drug screening and fluorescent imaging of human cancer cells in an in vivo microenvironment. We developed a workflow for large scale, automated drug screening on patient-derived leukemia samples in zebrafish using an automated fluorescence microscope equipped imaging unit.

Vídeos Relacionados

Read Article